Back

Right ventricular-arterial coupling measured by cardiac magnetic resonance associates with outcomes: insights from a large cohort of patients with tricuspid regurgitation

19 May 2025 (11:00 - 11:45)
Organised by: Logo
Congress Presentation Part of: Valve disease and heart failure - recognising opportunities Tricuspid Valve Disease HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Davide Margonato

San Raffaele Hospital, Milan (Italy)

3 More presentations in this session

Presentation thumbnail
Mitral valve prolapse: arrhythmic risk and prognosis
Doctor M. Dias (Braga, PT)
Abstract Slides Video
Presentation thumbnail
Catheter ablation in atrial fibrillation with concomitant mitral regurgitation: insights from the CABANA trial
Doctor S. Dhont (Genk, BE)
Abstract Slides Video
Presentation thumbnail
Development of tricuspid regurgitation after left-side heart surgery
Doctor M. Dias (Braga, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Valve disease and heart failure - recognising opportunities

The Event

Event poster

Heart Failure 2025

19 May 2025 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic implications of right ventricular-pulmonary arterial coupling derived from right ventricular strain in secondary tricuspid regurgitation
thumbnail
Congress Session
Advanced echocardiography for risk stratification in valve disease
thumbnail
Congress Presentation
Right ventricular-pulmonary arterial coupling for predicting death or heart failure admission in a broad population of patients with severe tricuspid regurgitation: data from the INTRICOR registry.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources